J. Hogan

发表

On the factors controlling the structural specificity and stereospecificity of the L-lactate dehydrogenase from Bacillus stearothermophilus: effects of Gln102.fwdarw.Arg and Arg171.fwdarw.Trp/Tyr double mutations

J. B. Jones, C. Kay, V. Martichonok, 1992 .

2-Aminopyrazolo[1,5-a]pyrimidines as potent and selective inhibitors of JAK2.

F. Salituro, S. Pazhanisamy, L. Swenson, 2009, Bioorganic & medicinal chemistry letters.

The marine cyanobacterial metabolite gallinamide A is a potent and selective inhibitor of human cathepsin L.

J. Mccammon, W. Gerwick, Hyukjae Choi, 2014, Journal of natural products.

Investigation of protein refolding using a fractional factorial screen: A study of reagent effects and interactions

T. Fox, James K Hogan, Melissa Swope Willis, 2005, Protein science : a publication of the Protein Society.

Improved specificity toward substrates with positively charged side chains by site-directed mutagenesis of the L-lactate dehydrogenase of Bacillus stearothermophilus.

J. B. Jones, M. Gold, J. Hogan, 1995, Biochemistry.

Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor.

M. Skolnick, A. Oliphant, D. Teng, 1997, Cancer research.

A study of reagent effects and interactions Investigation of protein refolding using a fractional factorial screen :

T. Fox, M. S. Willis, P. Prabhakar, 2005 .

Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune Diseases.

F. Salituro, Hui-Sheng Huang, Edmund M. Harrington, 2015, Journal of medicinal chemistry.

A novel chemotype of kinase inhibitors: Discovery of 3,4-ring fused 7-azaindoles and deazapurines as potent JAK2 inhibitors.

F. Salituro, Tiansheng Wang, A. Pierce, 2010, Bioorganic & medicinal chemistry letters.

Crystallization and preliminary X‐ray diffraction studies of two mutants of lactate dehydrogenase from Bacillus stearothermophilus

R. Kodandapani, M. James, J. B. Jones, 1992, Proteins.

VX-509 (Decernotinib) Is a Potent and Selective Janus Kinase 3 Inhibitor That Attenuates Inflammation in Animal Models of Autoimmune Disease

F. Salituro, S. Mahajan, D. Shlyakhter, 2015, The Journal of Pharmacology and Experimental Therapeutics.

VX-509 (Decernotinib) Is a Potent and Selective Janus Kinase 3 Inhibitor That Attenuates Inflammation in Animal Models of Autoimmune Disease

F. Salituro, S. Mahajan, D. Shlyakhter, 2015, The Journal of Pharmacology and Experimental Therapeutics.